Eccogene is a clinical stage biopharmaceutical company that is dedicated to providing innovative therapeutic solutions to address unmet medical needs globally. With a strong focus on metabolic and immune-related diseases, Eccogene specializes in disease biology, medicinal chemistry, and translational science. Committed to advancing its pipeline of drugs, Eccogene has a team of experienced drug hunters with a proven track record of discovering FDA-approved therapies.

At Eccogene, the company prides itself on its highly differentiated pipeline programs and innovative technology platforms. They develop novel therapies for metabolic and immune-related diseases, offering hope to patients in need. Their culture is centered around respect and care for life, reflecting their dedication to improving the health and well-being of individuals worldwide.

Based in both Shanghai, China, and Cambridge, MA, in the US, Eccogene is at the forefront of medical research and development. For further information, please visit their website or get in touch with their dedicated team at contact@eccogene. com